I migliori medici per il trattamento di Meningioma - TOP-32 medici

Il Dr. Solak ha completato una prestigiosa borsa di studio presso l'Istituto Oncologico dell'Università di Hacettepe, specializzandosi in casi oncologici complessi.

• Laureato presso l'Università di Hacettepe – una delle migliori facoltà di medicina della Turchia
• Ha completato la specializzazione presso l'Ospedale di Insegnamento e Ricerca Sisli Etfal di Istanbul
• Formazione presso il MD Anderson Cancer Center negli Stati Uniti
• Specializzato in tumori della mammella e gastrointestinali, tra gli altri

La Dott.ssa Eda Tanrikulu è specializzata in oncologia medica e chemioterapia presso l'Anadolu Medical Center, con un focus su casi complessi di cancro.

• Ha completato la formazione in oncologia medica presso l'Università di Marmara
• Classificata al 3º posto in Turchia nell'esame di specialità minore
• Ha diretto l'unità di oncologia medica presso l'ospedale di formazione e ricerca Haydarpaşa Numune
• Ha partecipato a studi clinici internazionali

Prof. Dr. Ahmet Hilmi Kaya is a professor of neurosurgery at Anadolu Medical Center in Gebze, Turkey. He earned his MD from Istanbul University Cerrahpaşa (English program). He completed his neurosurgery residency there from 1996 to 2003. He became a professor in 2015. He also completed observerships at Maastricht University in 2007 and 2009.

His clinical focus includes functional and stereotactic neurosurgery, including deep brain stimulation (DBS) for Parkinson’s disease and essential tremor. He also treats spinal tumors and spinal stenosis and performs spinal instrumentation. He manages skull base and brain tumors. He performs vascular surgery of the central nervous system.

Achievements include leading a Parkinson’s research project at Ondokuz Mayıs University (BAP, Project No. T.597, 2008). He supervised a neurosurgery thesis in 2008. His awards include third place at the 2nd National Congress of the Society of Neurosurgery in 2006, the Turkish Neurosurgical Society Overseas Scholarship in 2008, and the Aysima Altınok Thesis Award in 2009. Several of his papers ranked at the 22nd and 23rd Turkish Neurosurgical Society Scientific Congresses in 2008 and 2009. He is a member of the Turkish Neurosurgical Society and the Turkish Medical Association.

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.

• Provides immunotherapy, biological therapy, and hormone treatments for various cancer types.
• Treats rare and difficult conditions like thymoma, chordoma, and Ewing's sarcoma.
• Performs PET-CT scans and comprehensive oncological check-ups for men and women.
• Uses JCI-accredited facilities with systems like TrueBeam STx and Halcyon for treatment.

Il medico è specializzato nella gestione del cancro al seno, del colon-retto e dei tumori del sistema urogenitale. Con un'ampia esperienza dal 2014 presso l'Anadolu Medical Center, il medico ha precedentemente lavorato presso il Medical Park Hospital, l'Ospedale di Educazione e Ricerca Kocaeli Derince e l'Ospedale Regionale di Educazione e Ricerca di Erzurum. Il servizio militare del medico includeva un ruolo come specialista in Oncologia Medica presso l'Accademia Medica Militare di Gülhane.<\/p>

I successi educativi includono una laurea in medicina generale presso l'Università di Istanbul e specializzazioni in medicina interna e oncologia medica. Il medico è membro dell'Associazione Medica Turca, della Società Turca di Oncologia Medica e della Società Turca di Cancro del Polmone.<\/p>

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Dr. Turker Kilic is a neurosurgeon at Medical Park Göztepe Hospital Complex in Istanbul. He was the first Turkish physician to complete radiosurgery training at Sweden's Karolinska Institute. Dr. Kilic specializes in complex spine surgeries and Gamma Knife radiosurgery. He underwent postdoctoral research fellowships at Harvard Medical School and Brigham and Women’s Hospital.

• Won the Aesculap Research Prize from the European Association of Neurosurgical Societies.
• Received the Young Investigator Award from the AANS/CNS Section on Neurooncology.
• Served as President of the Nervous System Surgery Society.
• Practices at a JCI-accredited facility equipped with a Robotic Surgery Center of Excellence.

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.

• Nominated for the International Best Researcher Award for work on liver cancer.
• Leads clinical trials focused on targeted therapies and precision oncology.
• Member of the American Society of Clinical Oncology (ASCO).
• Certified by the European Society for Medical Oncology (ESMO).

Dr. Ozcan Yildiz is an oncologist and hematologist at Medipol Mega University Hospital in Istanbul. He specializes in treating complex neuroendocrine tumors and gynecological cancers. Dr. Yildiz has published numerous studies in prestigious journals like Medical Oncology and International Journal of Cardiology. He works at a JCI-accredited facility recognized for its bone marrow transplant expertise.

• Expertise in treating lung, breast, and gastrointestinal cancers.
• Treats hematological conditions including idiopathic thrombocytopenia.
• Published research on thyroid therapy and steroid synthesis safety.
• Performs specialized procedures like leukemia chemotherapy and tumor biopsies.

Il medico è un oncologo specializzato nel trattamento dei tumori al seno, ai polmoni e gastrointestinali. Attualmente, il medico pratica presso l'Ospedale Universitario Istinye Liv.

Con una carriera che si estende su molteplici istituzioni prestigiose, il medico ha servito come Specialista in Medicina Interna presso l'Ospedale Statale di Malatya, medico presso la Clinica Oncologica di Ankara e membro del Dipartimento di Oncologia presso l'Ospedale Regionale di Formazione e Ricerca di Erzurum.

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Selcuk e ha ottenuto il titolo di Professore Associato nel 2016.

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.